Osteoinduction by repeat plasmid injection of human bone morphogenetic protein-2

Journal of Gene Medicine

Volumn 12, Issue 12, 2010, Pages 937-944

  Osawa, Kenji ^a   Okubo, Yasunori ^a   Nakao, Kazumasa ^a   Koyama, Noriaki ^a   Bessho, Kazuhisa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bone; Bone morphogenetic protein; Injection; Nonviral gene transfer; Osteoinduction; Plasmid DNA

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MATURATION; BONE RADIOGRAPHY; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSSIFICATION; PATIENT SAFETY; PLASMID; PRIORITY JOURNAL; SAFETY; SKELETAL MUSCLE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MUSCLE, SKELETAL; OSTEOGENESIS; PLASMIDS;

MUS;

EID: 78650033588     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1515     Document Type: Article

References (32)

1. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994; 127: 1755-1766.
2. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990; 87: 2220-2224.
3. Bessho K, Carnes DL, Cavin R, Ong JL. Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2. J Biomed Mater Res 2002; 61: 61-65.
4. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84-A: 2123-2134.
5. Musgrave DS, Bosch P, Ghivizzani S, Robbins PD, Evans CH, Huard J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24: 541-547.
6. Betz OB, Betz VM, Nazarian A, et al. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 2007; 14: 1039-1044.
7. Vogt S, Wexel G, Tischer T, et al. The influence of the stable xpression of BMP-2 in fibrin clots on the remodeling and repair of osteochondral defects. Biomaterials 2009; 30: 2385-2392.
8. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244-2245.
9. Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.
10. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
11. Kim HJ, Greenleaf JF, Kinnick RR, Bronk JT, Bolander ME. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996; 7: 1339-1346.
12. Osawa K, Okubo Y, Nakao K, Koyama N, Bessho K. Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J Gene Med 2009; 11: 633-641.
13. Jiao S, Williams P, Berg RK, et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther 1992; 3: 21-33.
14. Zhang G, Budker V, Williams P, Hanson K, Wolff JA. Surgical procedures for intravascular delivery of plasmid DNA to organs. Methods Enzymol 2002; 346: 125-133.
15. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake S. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem Biophys Res Commun 1999; 262: 739-743.
16. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-199.
17. Fujimura K, Bessho K, Kusumoto K, Ogawa Y, Iizuka T. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 1995; 208: 316-322.
18. Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol 1966; 45: 290-296.
19. Okubo Y, Bessho K, Fujimura K, Iizuka T, Miyatake SI. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 2000; 267: 382-387.
20. Kawai M, Bessho K, Kaihara S, et al. Ectopic bone formation by human bone morphogenetic protein-2 gene transfer to skeletal muscle using transcutaneous electroporation. Hum Gene Ther 2003; 14: 1547-1556.
21. Kaihara S, Bessho K, Okubo Y, Sonobe J, Kawai M, Iizuka T. Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats. Gene Ther 2004; 11: 439-447.
22. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992; 1: 363-369.
23. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123.
24. Romero NB, Braun S, Benveniste O, et al. Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. Hum Gene Ther 2004; 15: 1065-1076.
25. Lee RC, Zhang D, Hannig J. Biophysical injury mechanisms in electrical shock trauma. Annu Rev Biomed Eng 2000; 2: 477-509.
26. McMahon JM, Wells KE, Bamfo JE, Cartwright MA, Wells DJ. Inflammatory responses following direct injection of plasmid DNA into skeletal muscle. Gene Ther 1998; 5: 1283-1290.
27. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005; 16: 329-345.
28. Gonda K, Nakaoka T, Yoshimura K, Otawara-Hamamoto Y, Harrii K. Heterotopic ossification of degenerating rat skeletal muscle induced by adenovirus-mediated transfer of bone morphogenetic protein-2 gene. J Bone Miner Res 2000; 15: 1056-1065.
29. Carlson BM, Faulkner JA. The regeneration of skeletal muscle fibers following injury: a review. Med Sci Sports Exerc 1983; 15: 187-198.
30. Liu R, Ginn SL, Lek M, et al. Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a. BMC Musculoskelet Disord 2009; 10: 51.
31. Hazama M, Aono A, Ueno N, Fujisawa Y. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem Biophys Res Commun 1995; 209: 859-866.
32. Hartikka J, Bozoukova V, Jones D, et al. Sodium phosphate enhances plasmid DNA expression in vivo. Gene Ther 2000; 7: 1171-1182.